Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Hiroshima City Hiroshima Citizens Hospital
Homepage:
city-hosp.naka.hiroshima.jp
Alternate name:
広島市立広島市民病院
ROR:
00wk7rn29
OpenAlex ID:
I4405283031
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
2017
·
Norikazu Masuda
, Soo-Jung Lee
, et al.
·
New England Journal of Medicine
·
1,892
PDF
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
2021
·
Torsten Zuberbier
, Amir Hamzah Abdul Latiff
, et al.
·
Allergy
·
1,254
PDF
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2022
·
Yoon-Koo Kang
, Li-Tzong Chen
, et al.
·
The Lancet Oncology
·
804
Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)
2020
·
Tohru Kobayashi
, Mamoru Ayusawa
, et al.
·
Pediatrics International
·
603
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
2022
·
Marcus Maurer
, Markus Magerl
, et al.
·
Allergy
·
535
PDF
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
2021
·
Eric P Winer
, Oleg Lipatov
, et al.
·
The Lancet Oncology
·
489
Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2019
·
Hironobu Hashimoto
, Masakazu Abe
, et al.
·
The Lancet Oncology
·
231
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
2019
·
Hiromichi Hamada
, Hiroyuki Suzuki
, et al.
·
The Lancet
·
207
Salivary gland tumors among atomic bomb survivors, 1950-1987
1997
·
Takashi Saku
, Yuzo Hayashi
, et al.
·
Cancer
·
169
PDF
Japanese Classification of Esophageal Cancer, 12th Edition: Part I
2024
·
Shinji Mine
, Koji Tanaka
, et al.
·
Esophagus
·
168
PDF
Extracorporeal cardiopulmonary resuscitation in adult patients with out-of-hospital cardiac arrest: a retrospective large cohort multicenter study in Japan
2022
·
Akihiko Inoue
, Toru Hifumi
, et al.
·
Critical Care
·
167
PDF
A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
2019
·
Satoshi Hamauchi
, Junji Furuse
, et al.
·
Cancer
·
158
PDF
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
2022
·
Marcus Maurer
, Markus Magerl
, et al.
·
World Allergy Organization Journal
·
156
PDF
Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events
2018
·
Masaru Miura
, Tohru Kobayashi
, et al.
·
Archives of Pediatrics and Adolescent Medicine
·
152
PDF
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study
2022
·
Hirotsugu Kenmotsu
, Kazushige Wakuda
, et al.
·
Journal of Thoracic Oncology
·
150
Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non–Small-Cell Lung Cancer With EGFR Mutation (IMPACT)
2021
·
Hirohito Tada
, Tetsuya Mitsudomi
, et al.
·
Journal of Clinical Oncology
·
147
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022
2022
·
Yukio Ozaki
, Hironori Hara
, et al.
·
Cardiovascular Intervention and Therapeutics
·
146
PDF
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
2019
·
Yasuhiro Fujiwara
, Hirofumi Mukai
, et al.
·
British Journal of Cancer
·
144
PDF
Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial
2015
·
Kazuaki Kaitani
, Koichi Inoue
, et al.
·
European Heart Journal
·
139
KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
2019
·
J. Cortés
, O. Lipatov
, et al.
·
Annals of Oncology
·
128
Remibrutinib in Chronic Spontaneous Urticaria
2025
·
Martin Metz
, Ana Giménez-Arnau
, et al.
·
New England Journal of Medicine
·
122
PDF
Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial
2015
·
Atsushi Kobori
, Satoshi Shizuta
, et al.
·
European Heart Journal
·
122
PDF
Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients
2025
·
Felix Busch
, Lena Hoffmann
, et al.
·
JAMA Network Open
·
117
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site
2020
·
Hidetoshi Hayashi
, Yuichi Takiguchi
, et al.
·
JAMA Oncology
·
116
PDF
Multicenter retrospective study to evaluate the efficacy and safety of the double‐flap technique as antireflux esophagogastrostomy after proximal gastrectomy ( rD ‐ FLAP Study)
2018
·
Shinji Kuroda
, Yasuhiro Choda
, et al.
·
Annals of Gastroenterological Surgery
·
115
PDF
Show more works
View as search
Works count:
1,547
Citation count:
27,800
Year
Topic
Type
